MENU
EXEL Exelixis Chart, History Price & Graph
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
EXEL and Stocks
Correlation & Price change
A.I.dvisor tells us that EXEL and RIGL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXEL and RIGL's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EXEL | 1D Price Change % | ||
|---|---|---|---|---|
| EXEL | 100% | -0.40% | ||
| RIGL - EXEL | 29% Poorly correlated | +0.18% | ||
| RVMD - EXEL | 28% Poorly correlated | -1.31% | ||
| ALGS - EXEL | 27% Poorly correlated | -0.61% | ||
| RARE - EXEL | 27% Poorly correlated | -2.20% | ||
| PLX - EXEL | 27% Poorly correlated | +13.71% | ||
More | ||||
Groups containing EXEL
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EXEL | 1D Price Change % |
|---|---|---|
| EXEL | 100% | -0.40% |
| modules theme (9 stocks) | 25% Poorly correlated | -3.68% |
| cancer theme (82 stocks) | 24% Poorly correlated | -5.37% |
| drugs theme (254 stocks) | 23% Poorly correlated | -4.03% |
| treatment theme (56 stocks) | 17% Poorly correlated | -4.29% |
| biotechnology theme (238 stocks) | 16% Poorly correlated | -4.32% |